A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms

被引：0
|
作者：
Mamiko Sakata-Yanagimoto
Yasuhisa Yokoyama
Hideharu Muto
Naoshi Obara
Naoki Kurita
Takayasu Kato
Yuichi Hasegawa
Yasushi Miyazaki
Mineo Kurokawa
Shigeru Chiba
机构：
[1] University of Tsukuba,Department of Hematology, Faculty of Medicine
[2] University of Tsukuba Hospital,Department of Hematology
[3] Nagasaki University,Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences
[4] The University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
来源：
Annals of Hematology | 2016年 / 95卷
关键词：
Follicular Lymphoma; Malignant Lymphoma; Nationwide Survey; Myeloproliferative Neoplasm; Myeloid Malignancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：829 / 830
页数：1
相关论文
共 50 条
  • [1] A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms
    Sakata-Yanagimoto, Mamiko
    Yokoyama, Yasuhisa
    Muto, Hideharu
    Obara, Naoshi
    Kurita, Naoki
    Kato, Takayasu
    Hasegawa, Yuichi
    Miyazaki, Yasushi
    Kurokawa, Mineo
    Chiba, Shigeru
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 829 - 830
  • [2] The co-occurrence of driver mutations in chronic myeloproliferative neoplasms
    Boddu, Prajwal
    Chihara, Dai
    Masarova, Lucia
    Pemmaraju, Naveen
    Patel, Keyur P.
    Verstovsek, Srdan
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2071 - 2080
  • [3] A Clinical Review of the Co-Occurrence of Myeloproliferative and Lymphoproliferative Neoplasms
    Krichevsky, Spencer
    Bhavsar, Erica B.
    Furman, Richard R.
    Niesvizky, Ruben
    Ritchie, Ellen K.
    Inghirami, Giorgio
    Scandura, Joseph
    BLOOD, 2018, 132
  • [4] The co-occurrence of driver mutations in chronic myeloproliferative neoplasms
    Prajwal Boddu
    Dai Chihara
    Lucia Masarova
    Naveen Pemmaraju
    Keyur P. Patel
    Srdan Verstovsek
    Annals of Hematology, 2018, 97 : 2071 - 2080
  • [5] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Cazzola, Mario
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
  • [6] The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
    Ragon, Brittany Knick
    Savona, Michael R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S37 - S42
  • [7] Epidemiology of myeloproliferative neoplasms and myelodysplastic syndromes in Germany
    Kraywinkel, Klaus
    ONKOLOGE, 2019, 25 (11): : 948 - 956
  • [8] Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes
    Thota, Swapna
    Gerds, Aaron T.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 803 - 812
  • [9] MOLECULAR ALTERATIONS ASSOCIATED WITH PROGRESSION OF MYELODYSPLASTIC SYNDROMES TO MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
    Valencia, A.
    Masala, E.
    Buchi, F.
    Sanna, A.
    Gozzini, A.
    Contini, E.
    Torricelli, F.
    Przychodzen, B.
    Maciejewski, J. P.
    Bosi, A.
    Santini, V.
    HAEMATOLOGICA, 2015, 100 : 54 - 54
  • [10] Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
    Xie, Wei
    Chen, Zhining
    Wang, So A.
    Hu, Shimin
    Li, Shaoying
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Tang, Guiling
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2993 - 3001
12345